The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20200231: Vistria Fund II, LP; Academic Partnerships, LLC
20200243: Mode Investor, LP; Comvest Investment Partners IV, L.P.
20200249: Henkel AG & Co. KGaA; Ares Corporate Opportunities Fund IV, L.P
Qualcomm Inc.
The FTC filed a complaint in federal district court charging Qualcomm Inc. with using anticompetitive tactics to maintain its monopoly in the supply of a key semiconductor device used in cell phones and other consumer products.
1911006 Informal Interpretation
20200169: Gulf Pacific Power, LLC; Enel S.p.A
20200170: Gulf Pacific Power, LLC; General Electric Company
20200179: Dexter Goei; Patrick Drahi
20200200: Wind Point Partners IX-A L.P; Ruben & Guadalupe Gutierrez
20200201: Olympus Growth Fund VII, L.P.; Adecco Group AG
20200207: Meritage Fund LLC; Warburg Pincus Private Equity XI, L.P.
20200208: Golden Gate Capital Opportunity Fund, L.P.; The Independent Order of Foresters
20200210: Hg Saturn A L.P.; General Atlantic Partners (Bermuda) III, L.P.
20200235: The Medical Society of South Carolina; CareAlliance Health Services d/b/a RSFH
20200236: Bon Secours Mercy Ministries; CareAlliance Health Services d/b/a RSFH
20200251: Vista Foundation Fund III, L.P.; Sonatype, Inc.
BunZai Media Group, Inc. (AuraVie)
In June 2018, the final two defendants among a group of California-based marketers were permanently barred from the deceptive marketing and billing tactics used in connection with selling skincare products offered to consumers with supposedly “risk-free” trials. The court order settled the charges against them, which the FTC announced in mid-2015. In all, 32 defendants who sold AuraVie, Dellure, LéOR Skincare, and Miracle Face Kit branded skincare products agreed to court orders with the FTC or had default orders entered against them. In November 2019, the FTC announced it was returning over $1.8 million to consumers who bought the deceptively marketed products.